Literature DB >> 9844829

Role of the CTLA-4 receptor in T cell activation and immunity. Physiologic function of the CTLA-4 receptor.

P Scheipers1, H Reiser.   

Abstract

Costimulatory molecules of the B7 family regulate the activation of T lymphocytes. T cell activation is promoted by binding of B7 molecules to CD28 and inhibited by binding to CTLA-4 (CD152). The balance between positive signals through CD28 and negative signals through CTLA-4 is critical for the fate of the T cell and is subject to tight regulation. Recent in vitro and in vivo studies have significantly advanced our understanding of the function of the CTLA-4 receptor. The results of these experiments suggest that CTLA-4 is critical for the induction of self-tolerance, and that it may have distinct signaling functions in resting and activated T cells. In resting T cells, CTLA-4 crosslinking leads to cell-cycle arrest, whereas in activated T cells, CTLA-4 crosslinking induces apoptosis. In this article, we will review the physiologic functions of the CTLA-4 receptor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9844829     DOI: 10.1007/BF02788753

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  90 in total

Review 1.  Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases.

Authors:  H Reiser; M J Stadecker
Journal:  N Engl J Med       Date:  1996-10-31       Impact factor: 91.245

2.  T:T antigen presentation by activated murine CD8+ T cells induces anergy and apoptosis.

Authors:  J G Chai; I Bartok; D Scott; J Dyson; R Lechler
Journal:  J Immunol       Date:  1998-04-15       Impact factor: 5.422

3.  Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes.

Authors:  L Van Parijs; A Biuckians; A K Abbas
Journal:  J Immunol       Date:  1998-03-01       Impact factor: 5.422

Review 4.  Biochemical features of anergic T cells.

Authors:  C C Maier; M I Greene
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

5.  Immobilized anti-CD3 mAb induces anergy in murine naive and memory CD4+ T cells in vitro.

Authors:  J G Chai; R I Lechler
Journal:  Int Immunol       Date:  1997-07       Impact factor: 4.823

6.  Interactions of CD80 and CD86 with CD28 and CTLA4.

Authors:  J H Ellis; M N Burden; D V Vinogradov; C Linge; J S Crowe
Journal:  J Immunol       Date:  1996-04-15       Impact factor: 5.422

7.  Regulation of CTLA-4 expression during T cell activation.

Authors:  D Perkins; Z Wang; C Donovan; H He; D Mark; G Guan; Y Wang; T Walunas; J Bluestone; J Listman; P W Finn
Journal:  J Immunol       Date:  1996-06-01       Impact factor: 5.422

8.  CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand.

Authors:  K Saoulli; S Y Lee; J L Cannons; W C Yeh; A Santana; M D Goldstein; N Bangia; M A DeBenedette; T W Mak; Y Choi; T H Watts
Journal:  J Exp Med       Date:  1998-06-01       Impact factor: 14.307

9.  Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.

Authors:  H Groux; M Bigler; J E de Vries; M G Roncarolo
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

10.  B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28.

Authors:  F Fallarino; P E Fields; T F Gajewski
Journal:  J Exp Med       Date:  1998-07-06       Impact factor: 14.307

View more
  11 in total

Review 1.  Itch regulation of innate and adaptive immune responses in mice and humans.

Authors:  Natania S Field; Emily K Moser; Paula M Oliver
Journal:  J Leukoc Biol       Date:  2020-04-30       Impact factor: 4.962

Review 2.  Identifying and managing the adverse effects of immune checkpoint blockade.

Authors:  Arthur Winer; J Nicholas Bodor; Hossein Borghaei
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

Review 3.  Photothermal therapies to improve immune checkpoint blockade for cancer.

Authors:  Preethi B Balakrishnan; Elizabeth E Sweeney; Anvitha S Ramanujam; Rohan Fernandes
Journal:  Int J Hyperthermia       Date:  2020-12       Impact factor: 3.914

Review 4.  Key issues in the management of patients with systemic lupus erythematosus: latest developments and clinical implications.

Authors:  Natasha Jordan; David D'Cruz
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-12       Impact factor: 5.346

5.  Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients.

Authors:  Cheng-Lin Zhu; Qiang Huang; Chen-Hai Liu; Fang Xie
Journal:  Mol Biol Rep       Date:  2012-06-19       Impact factor: 2.316

6.  Programmed death 1 regulates development of central memory CD8 T cells after acute viral infection.

Authors:  S Rameeza Allie; Weijun Zhang; Shinchiro Fuse; Edward J Usherwood
Journal:  J Immunol       Date:  2011-04-27       Impact factor: 5.422

7.  A type 1 diabetes subgroup with a female bias is characterised by failure in tolerance to thyroid peroxidase at an early age and a strong association with the cytotoxic T-lymphocyte-associated antigen-4 gene.

Authors:  J M M Howson; D B Dunger; S Nutland; H Stevens; L S Wicker; J A Todd
Journal:  Diabetologia       Date:  2007-02-14       Impact factor: 10.122

8.  Targeting Angiotensin II Type-1 Receptor (AT1R) Inhibits the Harmful Phenotype of Plasmodium-Specific CD8+ T Cells during Blood-Stage Malaria.

Authors:  João L Silva-Filho; Celso Caruso-Neves; Ana A S Pinheiro
Journal:  Front Cell Infect Microbiol       Date:  2017-02-16       Impact factor: 5.293

Review 9.  Novel therapeutic agents in clinical development for systemic lupus erythematosus.

Authors:  Natasha Jordan; Pamela M K Lutalo; David P D'Cruz
Journal:  BMC Med       Date:  2013-05-03       Impact factor: 8.775

Review 10.  Current and emerging treatment options in the management of lupus.

Authors:  Natasha Jordan; David D'Cruz
Journal:  Immunotargets Ther       Date:  2016-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.